Form4insider filings, from the source

SEC Form 4 · accession 0001562180-18-004678

REGENXBIO Inc. · RGNX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kenneth T. Mills
Officer — President and CEO · Director
Period of report
Nov 21, 2018
Accepted (ET)
Nov 26, 2018 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590877

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Nov 21, 2018S1,300$60.09D284,700D
Common StockF3Nov 21, 2018S6,802$61.22D277,898D
Common StockF4Nov 21, 2018S6,898$61.92D271,000D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses